|
|
Defining the functional organization of cerebellar output circuits that control feeding behavior |
| 3R01DK124801-02S1 |
|
NIDDK |
2022 |
|
|
Mechanisms of immunoproteasome-mediated metabolic disorders |
| 3R01DK125039-03S1 |
|
NIDDK |
2022 |
|
|
12/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
| 3U01DK048339-28S2 |
|
NIDDK |
2022 |
|
|
6/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
| 3U01DK048375-28S1 |
|
NIDDK |
2022 |
|
|
15/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
| 3U01DK048387-28S1 |
|
NIDDK |
2022 |
|
|
17/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
| 3U01DK048400-28S1 |
|
NIDDK |
2022 |
|
|
9/22 Limited Competition for Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
| 3U01DK048411-28S1 |
|
NIDDK |
2022 |
|
|
4/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Clinical Center |
| 3U01DK048434-28S1 |
|
NIDDK |
2022 |
|
|
Randomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER) |
| 3U01DK123786-01S1 |
|
NIDDK |
2022 |
|
|
Enteric Neuronal Aggregation of a-synuclein causes disruption in Colonic Neurotransmission and results in Colonic Dysmotility |
| 5F30DK124987-03 |
|
NIDDK |
2022 |